|
Most scientists don’t think about this, but if you’re culturing cells with FBS, you’re also including a wildly batch-variable, undefined mix of protease inhibitors with downstream consequences for cell biology. The presence of protease inhibitors in FBS is critical for passaging cells with trypsin; these proteins are responsible for deactivating trypsin (assuming you’re using FBS-containing media to quench the reaction, rather than a separate trypsin inhibitor). Unfortunately protease inhibitors are more problematic during the culture process than most people realize - but odds are you’ve never even thought about the impact they’re having on your cells. Protease inhibitors regulate processes like ECM turnover/remodeling, cell-matrix signaling, or migration, invasion, and differentiation. So adding an undefined mix of protease inhibitors to your cultures, courtesy of FBS, inevitably has an impact. This is particularly relevant for studies linked to fibrosis, cancer invasion, differentiation, or organoid/3D culture systems. Here’s where it gets even more interesting: many scientists assume growth factor variation drives most of FBS batch variation, and this does play a role. However, protease inhibitor variation is very much present, largely unappreciated, and has major implications for our research studies. These variable protease inhibitors control how much cells can cut up and remodel their surrounding matrix. If one serum batch inhibits proteases more than another, cells will migrate differently, invade differently, remodel ECM differently, and respond differently to exactly the same experimental signals. So when it comes to publishing research results using different batches of FBS, ECM-related results can vary substantially. That’s a big reason experiments involving migration, invasion, fibrosis, or 3D cultures can be so hard to reproduce. And this is also why many scientists whose experimental readouts depend on ECM dynamics can and should consider working with chemically defined systems.
As always, literature below if you're keen to dive deeper! For more reading: Page-McCaw et al. - for a review on how protease activity controls ECM remodeling, signaling, and cell behavior. https://www.nature.com/articles/nrm2125 Bonnans et al. - shows how protease regulation impacts cancer and fibrosis. https://www.nature.com/articles/nrm3904 Gjorevski et al. - A deeper dive into how chemically defined, tunable systems are important for reproducibility in the context of ECM composition and remodeling studies. https://www.nature.com/articles/nature20168 Not FBS specific, but one of the older papers on protease inhibitors in serum. Love a good study from the 1950s: https://pubmed.ncbi.nlm.nih.gov/14946322/
0 Comments
If you scroll through the formulations for most foundational basal media (DMEM, RPMI, MEM, etc), here’s what you won’t find: Lipids.
These basal media were created over 50 years ago, before lipid metabolism and membrane biology were well understood. As such, you won’t find key fatty acids, cholesterol, and the delivery systems required to supply them to cells for efficient uptake. This is just one of the many, many reasons that scientists include fetal bovine serum in their cell culture media; it delivers lipid complexity. However, you'll notice a surprising number of serum-free media recipes don’t include many - sometimes any - lipids. This may appear okay for short-term cell growth, or even growth of particularly robust cell lines. But it does have an underappreciated impact. Without lipids, cells often end up with altered membrane composition, shifted eicosanoid pathways, ER stress, and/or rewired inflammatory signaling. Phenotypes like morphology, proliferation rate, and oxidative stress sensitivity often reflect this underlying lipid deficit. This is something we thought a lot about when developing our chemically defined FBS replacement. And it’s something for you to think about if you’re trying to eliminate serum from your cell culture; are you incorporating the right lipids for your cells, and do you have the right strategy to ensure their bioavailability? As always, journal articles below if you want to dive deeper 😊 https://pmc.ncbi.nlm.nih.gov/articles/PMC5661806/ Following a recent article for Beyond Animal Research in New Zealand about the use and limitations of foetal bovine serum (FBS) and Media City's alternative 'FRS Pioneer', I was asked to put together a similar article for Animal-Free Science Advocacy in Australia. Here is a link to the article: Foetal Bovine Serum finally has a superior replacement alternative  |
What's been happening?Sharing the Media City journey has been important to us because we want to encourage the next generation of scientists to establish companies that will advance scientific research. Check back regularly for the "building in public" updates on what it looks like to establish a scientific company. Archives
January 2026
Categories |
RSS Feed
